Glucocorticoid receptor in T cells mediates protection from autoimmunity in pregnancy.
Jan Broder EnglerNina KursaweMaría Emilia SolanoKostas PatasSabine WehrmannNina HeckmannFred LühderHolger M ReichardtPetra Clara ArckStefan M GoldNicolaus KrögerPublished in: Proceedings of the National Academy of Sciences of the United States of America (2017)
Pregnancy is one of the strongest inducers of immunological tolerance. Disease activity of many autoimmune diseases including multiple sclerosis (MS) is temporarily suppressed by pregnancy, but little is known about the underlying molecular mechanisms. Here, we investigated the endocrine regulation of conventional and regulatory T cells (Tregs) during reproduction. In vitro, we found the pregnancy hormone progesterone to robustly increase Treg frequencies via promiscuous binding to the glucocorticoid receptor (GR) in T cells. In vivo, T-cell-specific GR deletion in pregnant animals undergoing experimental autoimmune encephalomyelitis (EAE), the animal model of MS, resulted in a reduced Treg increase and a selective loss of pregnancy-induced protection, whereas reproductive success was unaffected. Our data imply that steroid hormones can shift the immunological balance in favor of Tregs via differential engagement of the GR in T cells. This newly defined mechanism confers protection from autoimmunity during pregnancy and represents a potential target for future therapy.
Keyphrases
- multiple sclerosis
- preterm birth
- regulatory t cells
- disease activity
- pregnancy outcomes
- rheumatoid arthritis
- mass spectrometry
- systemic lupus erythematosus
- pregnant women
- ms ms
- ankylosing spondylitis
- rheumatoid arthritis patients
- juvenile idiopathic arthritis
- social media
- oxidative stress
- artificial intelligence
- high resolution
- high glucose
- machine learning
- single molecule
- atomic force microscopy
- estrogen receptor
- smoking cessation
- high speed